Hyperthyroidism — caused by excessive thyroid hormone production, usually from benign thyroid adenoma — is the most common endocrine disorder in older cats. First described only in 1979, it is now diagnosed in approximately 10% of cats over 10 years of age in developed countries. Understanding its welfare impacts and optimal management is essential for companion animal veterinary care.
Untreated hyperthyroidism causes significant welfare compromise despite the paradox that affected cats often appear energetic or even hyperactive. The subjective experience includes:
The combination of constant hunger, cardiovascular stress, GI discomfort, and muscle weakness creates a sustained welfare deficit that persists until treatment is initiated.
Hyperthyroidism is diagnosed by measuring serum total thyroxine (TT4). Regular senior wellness screening — including TT4 measurement in cats over 7-8 years — enables early diagnosis before severe clinical signs develop. Early diagnosis and treatment prevents unnecessary suffering.
Multiple evidence-based treatment options exist, each with welfare considerations:
A critical welfare consideration is the relationship between hyperthyroidism and concurrent chronic kidney disease (CKD). Hyperthyroidism elevates glomerular filtration rate, masking underlying CKD. Treatment can unmask pre-existing CKD, sometimes requiring adjustment of treatment targets. This relationship requires careful monitoring and individualized management.
Successfully treated hyperthyroid cats typically experience significant quality of life improvement — restoration of normal weight, reduced anxiety, normal cardiovascular function, and improved coat quality. Long-term welfare monitoring through regular check-ups maintains treatment efficacy and quality of life in the senior years.